Generic medicine

Neostigmine Methyl Sulphate: Brands, Price & Uses in Bangladesh

Neostigmine Methyl Sulphate is a reversible acetylcholinesterase inhibitor with the following clinically established uses: Reversal of non-depolarizing neuromuscular blockade: FDA-approved for…

Forms:Injection

About Neostigmine Methyl Sulphate

Indications of Neostigmine Methyl Sulphate

Neostigmine Methyl Sulphate is a reversible acetylcholinesterase inhibitor with the following clinically established uses:

  • Reversal of non-depolarizing neuromuscular blockade: FDA-approved for reversing the effects of non-depolarizing neuromuscular blocking agents after surgical procedures, always given together with an anticholinergic agent (atropine or glycopyrrolate).
  • Myasthenia gravis: Guideline-supported symptomatic treatment (parenteral use) when oral therapy is not feasible, such as in the immediate postoperative period or during a myasthenic crisis under close monitoring.
  • Postoperative/postpartum non-obstructive urinary retention: Established adjunct use to stimulate bladder detrusor tone in the absence of mechanical obstruction.
  • Postoperative abdominal distension (paralytic ileus): Established use to stimulate gastrointestinal motility in non-obstructive ileus.

Neostigmine Methyl Sulphate is administered only by trained healthcare personnel with appropriate monitoring equipment available.

Dosage & Administration of Neostigmine Methyl Sulphate

IndicationAdult DoseNotes
Reversal of non-depolarizing neuromuscular blockade0.03–0.07 mg/kg IV bolus (maximum total dose 0.07 mg/kg or 5 mg, whichever is less); may repeat based on response and neuromuscular monitoringMust be given with an anticholinergic agent (atropine ~15 mcg/kg IV or glycopyrrolate ~10 mcg/kg IV) shortly before or concurrently; use only when first twitch response has recovered to at least 10% of baseline on a peripheral nerve stimulator
Myasthenia gravis (parenteral)1–2.5 mg IM or SC at appropriately spaced intervals; total daily dose individualized (commonly 5–20 mg/day) according to responseDose is titrated to the smallest amount that controls symptoms without inducing cholinergic side effects; oral therapy resumed as soon as feasible
Postoperative/postpartum non-obstructive urinary retention0.25–0.5 mg IM or SC, repeated every 3 to 6 hours as neededOnly after mechanical obstruction has been excluded
Postoperative abdominal distension (paralytic ileus)0.25–0.5 mg IM or SC, repeated every 3 to 6 hours as neededOnly after mechanical obstruction/peritonitis has been excluded

Neostigmine Methyl Sulphate must be administered by trained healthcare personnel with resuscitation equipment, oxygen, and atropine immediately available. It is given by intravenous, intramuscular, or subcutaneous injection as appropriate to the indication; it is not given orally in this formulation.

Side Effects of Neostigmine Methyl Sulphate

Side effects of Neostigmine Methyl Sulphate arise mainly from excessive cholinergic (muscarinic and nicotinic) stimulation:

  • Most common: Bradycardia, nausea, and vomiting.
  • Cardiovascular: Arrhythmias, hypotension, tachycardia, syncope, and rarely cardiac arrest.
  • Gastrointestinal: Increased salivation, abdominal cramps, diarrhea, dry mouth, flatulence.
  • Respiratory: Increased bronchial and pharyngeal secretions, bronchospasm, dyspnea, respiratory depression.
  • Neuromuscular/CNS: Muscle weakness, muscle cramps/fasciculations, dizziness, drowsiness, headache, convulsions (rare).
  • Dermatologic: Sweating, flushing, rash, urticaria.
  • Allergic: Hypersensitivity reactions including anaphylaxis (rare but serious).

Excessive dosing can precipitate a cholinergic crisis (see Overdose).

Contraindications of Neostigmine Methyl Sulphate

Neostigmine Methyl Sulphate is contraindicated in:

  • Known hypersensitivity to neostigmine or to any component of the formulation (including bromide/sulfate salt components).
  • Mechanical intestinal obstruction.
  • Mechanical obstruction of the urinary tract.
  • Peritonitis.

Frequently Asked Questions about Neostigmine Methyl Sulphate

What is Neostigmine Methyl Sulphate used for?

Neostigmine Methyl Sulphate is used to reverse the effects of certain muscle relaxants (non-depolarizing neuromuscular blocking agents) given during surgery, to treat symptoms of myasthenia gravis when oral medicine cannot be used, and to relieve non-obstructive urinary retention or abdominal bloating (paralytic ileus) after surgery or childbirth.

How is Neostigmine Methyl Sulphate given?

Neostigmine Methyl Sulphate is given as an injection — into a vein, muscle, or under the skin — by a trained healthcare professional in a hospital or clinical setting, along with an anticholinergic medicine such as atropine to prevent unwanted side effects. It is not taken by mouth in this form.

Who should not receive Neostigmine Methyl Sulphate?

Neostigmine Methyl Sulphate should not be given to anyone with a known allergy to it, anyone with a mechanical blockage of the intestine or urinary tract, or anyone with peritonitis (inflammation of the lining of the abdomen), since increasing muscle contraction against a physical blockage can be dangerous.

What are the common side effects of Neostigmine Methyl Sulphate?

Common side effects of Neostigmine Methyl Sulphate include slow heart rate, nausea, vomiting, increased saliva and sweating, stomach cramps, and muscle weakness. Because these are caused by overstimulation of the same system the drug targets, your medical team will monitor you closely and may give additional medicine (like atropine) to control them.

Is Neostigmine Methyl Sulphate safe during pregnancy or breastfeeding?

Neostigmine Methyl Sulphate should be used in pregnancy only if clearly needed, since it may cause uterine contractions and premature labor if given near term, and because there is limited human safety data. It is not known whether it passes into breast milk, so a doctor should weigh the benefit to the mother against any potential risk to the infant before it is used while breastfeeding.

What happens if too much Neostigmine Methyl Sulphate is given?

An overdose of Neostigmine Methyl Sulphate can cause a cholinergic crisis, with symptoms such as excessive sweating and salivation, vomiting, very slow heart rate, and progressive muscle weakness that can affect breathing. This is a medical emergency requiring immediate treatment by trained staff, typically with atropine and breathing support, so anyone showing these signs needs urgent medical attention right away.

Disclaimer

The information provided is accurate to the best of our knowledge, but it does not replace professional medical advice. We cannot guarantee its completeness or accuracy, and the absence of specific information about a drug should not be taken as an endorsement. We are not responsible for any consequences arising from this information, so please consult a healthcare professional for any concerns or questions.

DoctorBlogArticles